AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06189690 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS
Description: Repetitive TMS will be administered by a MagPro R30 stimulator and an active/placebo MCF-B70 A/P coil. All participants will use two surface electrodes to simulate rTMS skin sensations near to stimulation site. rTMS/sham conditions will be double-blinded by a USB stick. The USB contains the information about rTMS/sham condition and this is not available to the stimulator operator. Parameters of rTMS were previously described.
Study NCT05600660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib
Description: Orelabrutinib will be given as 150 mg/d orally 72h after MTX infusion or MTX clearance, every 21 days for 6 cycles during induction treatment.~Daily Orelabrutinb will be administered as maintenance treatment for up to 1 year or until disease progression, intolerable toxicity, death, informed consent withdrawal or lost of follow up (whichever occurs first).
Study NCT05600660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375mg/m2 intravenous infusion d1, every 3 weeks for 1 cycle, 6 cycles will be prescribed for induction therapy.
Study NCT05600660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: 3.5g/m2 intravenous infusion for 4 hours in d1, every 21 days for 1 cycle, 6 cycles will be prescribed.
Study NCT05384964 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire completed by ICU nurses
Study NCT06060184 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Next-Generation Sequencing (NGS)
Description: Sequencing of genomes (Long read NGS)
Study NCT06477926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-668 IR
Description: • Oral Capsule
Study NCT06477926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-668 ER
Description: • Oral Tablets
Study NCT06750406 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mind body exercises
Description: intervention might consist of a structured program of mind-body exercises designed specifically for pregnant women. This could involve a combination of yoga sessions, mindfulness meditation practices, deep breathing exercises, and progressive muscle relaxation techniques. The duration of these sessions will be 45 to 60 minutes each, with a recommended frequency of 2-3 times per week for 8 weeks
Study NCT06750406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: relaxation exercises
Description: It involves relaxation exercises including deep breathing, relaxing postures etc. The duration of these sessions will be 45 to 60 minutes each, with a recommended frequency of 2-3 times per week for 8 weeks
Study NCT06749665 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: polidacanol 3%
Description: Aethoxysklerol 3%,60mg/ ml ampoule, kreussler pharma, Germany
Study NCT06749665 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: candida antigen
Description: delayed type of hypersensitivity reaction is induced toward the injected antigen and the wart virus as well. This can increase the ability of the immune system to recognize and eradicate the human papillomavirus on various parts of the body and eliminate the necessity of local treatment for each wart
Study NCT06750783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xuezhikang
Description: The Xuezhikang group takes Xuezhikang at a dose of 600 milligrams twice a day, orally after meals;
Study NCT06750783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: The atorvastatin group takes atorvastatin 20mg once a day, orally after meals.
Study NCT06750653 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CeraVe Moisturizing Cream
Description: CeraVe is a formulation of Purified Water, Glycerin, Cetareth-20 and Cetearyl Alcohol, Caprylic/Capric Triglyceride, Behentrimonium Methosulfate and Cetearyl Alcohol, Cetyl Alcohol, Petrolatum, Dimethicone, Hyaluronic Acid, Ceramide 1, Ceramide 3, Ceramide 6-II, Cholesterol, Phytosphingosine, Potassium Phosphate, Dipotassium phosphate, Phenoxyethanol, Methylparaben, Propylparaben, Disodium EDTA, Sodium Lauroyl Lactylate, Carbomer, Xanthan Gum, manufactured by L'Oréal, for topical skin use.
Study NCT06750653 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vaseline
Description: Vaseline is a formulation of active ingredient white petrolatum, USP (100%), manufactured by Unilever, for topical skin use.
Study NCT06749158 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: spontaneous bone regeneration
Description: stage 1 surgery:~1. after administration of Local anesthesia (articaine hydrochloride 68 mg/1.7 ml + adrenaline 0.017 mg/1.7 ml injectable solution), sulcular incision will be done , extending two teeth beyond the area of interest followed by two oblique incisions on either side of the flap~2. after flap elevation, enucleation of the cystic lesion and extraction of the non-restorable teeth related to the lesion will be done.~3. titanium mesh will be tailored with 3 mm overlap at the edges to cover the bone window completely and fixed to the bone using mono-cortical titanium screws.~This will be followed by:~* proper decompression of soft tissue to achieve tension-reduced suture.~* Primary closure will be performed using 4-0 vicryl sutures.~* Sutures will be removed one week postoperatively. stage 2 surgery(after 6 months):~  1. titanium mesh and screws will be removed.~ 2. core biopsy will be obtained for histological assessment~ 3. implant/s placement.
Study NCT06749158 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: guided bone regeneration
Description: stage 1 surgery after cyst enucleation and extraction of the non-restorable teeth related to the lesion, The intra-bony defect will be filled with Deproteinized Bovine Bone.~* Titanium mesh will be tailored with 3mm overlap at the edges to cover the bone window completely and fixed to the bone using mono-cortical titanium screws. This will be followed by:~* proper decompression of soft tissue will be applied to achieve tension-reduced suture.~* Primary closure will be performed using 4-0 vicryl sutures.~* Sutures will be removed one week postoperatively. stage 2 surgery(6 months later) :~  1. titanium mesh will be removed.~ 2. core biopsy will be obtained for histological assessment.~ 3. implant/s placement.
Study NCT06749093 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Filtered Air (FA)
Description: Exposure to HEPA filtered air, as a control
Study NCT06749093 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wood Smoke (WS)
Description: Wood smoke (WS) standardized to 300µg/m³ of particulate matter with a diameter of 2.5 micrometers or less (PM2.5).
Study NCT06749093 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diesel Exhaust (DE)
Description: Diesel exhaust (DE) standardized to 300µg/m³ of particulate matter with a diameter of 2.5 micrometers or less (PM2.5).
Study NCT06749093 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diesel Exhaust and Wood Smoke (DEWS)
Description: Combined diesel exhaust and wood smoke standardized to 300µg/m³ of particulate matter with a diameter of 2.5 micrometers or less (PM2.5).
Study NCT06748300 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: web- based education
Description: breastfeeding education
Study NCT06749691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal Irinotecan and Apatinib
Description: Liposomal Irinotecan in Combination With Apatinib
Study NCT06748248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: suspension Therapy
Description: suspension therapy for individuals with Down syndrome is an approach that focuses on improving mobility and balance through different activities that will be conducted through universal exercise unit. This method involves organizing individuals with Down syndrome into two groups. Group A will perform Suspension Therapy in addition to routine physical therapy. These routine exercises will consist of stretching exercises (arm raises, chest stretch, leg swings, hamstring stretch, cat-cow poses, starfish stretch), strength and endurance training (like stepping, carrying light weights) and balance training (playing hopscotch and kicking a ball). The exercise program will gradually increase in intensity in accordance with each participant's functional improvement. Suspension Therapy will consist of passive and active postural auto-correction exercises done repeatedly and based on kinesthetic and sensorimotor principles. Repeated corrective movements will be performed.
Study NCT06748248 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine Treatment
Description: Group B will perform routine physical therapy (RPT) alone. These routine exercises will consist of stretching exercises (particularly upper and lower body stretches and full body stretches). Stretches will be gentle and avoid bouncing. Hold for each stretch will be 15-30 seconds. Balance and coordination exercises (Walking on balance beams, obstacle courses) will be performed as RPT. The exercise program will gradually increase in intensity in accordance with each participant's functional improvement. These exercises will be carried out 5 days in a week for one hour daily.~Data will be assessed by assessor at baseline and at the end of 5th session of treatment (Pre and post).
Study NCT06277557 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual Reality
Description: Virtual reality learning platform as intervention in this study
Study NCT04966832 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XW10508
Description: XW10508 capsules or tablets
Study NCT04966832 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules or tablets
Study NCT06628817 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: The Intensive Care Bundle with Mortality Reduction
Description: a continuous automated medical quality monitoring and feedback system on the online platform, self-feedback and teamwork based on video conferencing, multidisciplinary online education, offline on-site supervision, and standardized intervention in the behavior of medical actors in the process of stroke treatment.
Study NCT06628791 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BK329
Description: Lactococcus lactics. subsp. lactis CAB701(KCCM13360P) 400 mg/day for 12 weeks
Study NCT06628791 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 400 mg/day for 12 weeks
Study NCT06630975 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hemiepiphysiodesis
Description: 8 plate
Study NCT06630975 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hemiepiphysiodesis
Description: 8 plate
Study NCT06630975 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hemiepiphysiodesis
Description: 8 plate
Study NCT06630975 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Eight-Plates first described by Stevens are simple to use
Description: fewer complications in terms of implant loosening and fracture can be expected.Good results as well as low rebound and complication rates have been recorded
Study NCT06630975 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Eight-Plates first described by Stevens are simple to use
Description: fewer complications in terms of implant loosening and fracture can be expected.Good results as well as low rebound and complication rates have been recorded
Study NCT06630975 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Eight-Plates first described by Stevens are simple to use
Description: fewer complications in terms of implant loosening and fracture can be expected.Good results as well as low rebound and complication rates have been recorded
Study NCT06630975 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hemiepiphysiodesis by eight Plate
Description: Extraperiosteal eight plate insertion
Study NCT06630975 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hemiepiphysiodesis by eight Plate
Description: Extraperiosteal eight plate insertion
Study NCT06630975 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hemiepiphysiodesis by eight Plate
Description: Extraperiosteal eight plate insertion
Study NCT04158024 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block
Description: The ESPB is a fascial plane block performed by injecting local anesthetic between the erector spinae muscle and the transverse process. Its proposed mechanism of action is via blockade of the dorsal and ventral rami of the thoracic spinal nerves and sympathetic fibers.
Study NCT05804435 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iNod™ System
Description: The iNod™ Ultrasound Imaging System enables visualization of endobronchial lesions, peripheral lung nodules, or lung masses (referred to as lesions) using R-EBUS and performance of lung biopsy under direct R-EBUS visualization.
Study NCT05472155 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bulb syringe
Description: Suctioning with a bulb syringe
Study NCT05472155 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Suction catheter
Description: Suctioned with a suction catheter
Study NCT05709652 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Aortic CTA, .23s
Description: Aortic CTA performed with short (0.23 sec) gantry rotation time.
Study NCT05709652 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Aortic CTA, .28s
Description: Aortic CTA performed with standard (.28 sec) gantry rotation time.
Study NCT06301113 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: CBD infused candy
Description: 300 Nano mg CBD Candy cherry flavor
Study NCT06301113 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Sugar free Candy
Description: Raspberry flavored sugar free candy
Study NCT05294835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: ketamine infusion
Study NCT05068037 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ACUPUNCTURE
Description: standard acupuncture TCM (analgesia, vomiting)
Study NCT05068037 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ANTIEMETICS
Description: NO ACUPUNCTURE, WITH ANTIEMETICS
Study NCT05068037 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NOTHING
Description: NO ACUPUNCTURE, NO ANTIEMETICS
Study NCT05029934 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: use of EndoClot
Description: deployment of EndoClot adhesive spray
Study NCT05029934 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: use of EndoClot
Description: deployment of EndoClot adhesive spray
Study NCT06347718 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: anti-CD19 CAR T cell therapy
Description: Single-dose
Study NCT05709873 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Imagery rehearsal therapy
Description: Therapy to reduce nightmares, delivered via videoconference sessions
Study NCT05709873 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Targeted dream control
Description: Therapy to reduce nightmares, delivered in videoconference sessions and lab session. Lab session will involve a sleep study during a daytime nap.
Study NCT04946136 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gait modification
Description: Individualized gait modifications guided by real-time visual feedback of knee load
Study NCT05976724 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TENS, exercise
Description: TENS: The patients were sat in a chair positioned next to a treatment table. The hand to be treated was placed on the treatment table with the forearm in the supine position. Electrodes were then placed on the transverse carpal ligament and palmar surface of the hand. Conventional TENS was applied, with the current transition time set to 50-100 µs, and performed at a frequency of 100 Hz for a period of 20 minutes at an amplitude that did not cause muscle contraction or any feeling of numbness or tingling.~The supervised exercises were performed by the patients in a seated position. Strengthening exercises were performed with both hands by means of Digi-Flex hand exerciser (IMC Products Corp, Hicksville, New York), modeling mass and elastics. The patients were tasked with performing these exercises 10 times in each session and three times daily.
Study NCT05976724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TENS, exercise
Description: TENS: The patients were sat in a chair positioned next to a treatment table. The hand to be treated was placed on the treatment table with the forearm in the supine position. Electrodes were then placed on the transverse carpal ligament and palmar surface of the hand. Conventional TENS was applied, with the current transition time set to 50-100 µs, and performed at a frequency of 100 Hz for a period of 20 minutes at an amplitude that did not cause muscle contraction or any feeling of numbness or tingling.~The supervised exercises were performed by the patients in a seated position. Strengthening exercises were performed with both hands by means of Digi-Flex hand exerciser (IMC Products Corp, Hicksville, New York), modeling mass and elastics. The patients were tasked with performing these exercises 10 times in each session and three times daily.
Study NCT05976724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan mobilisation
Description: Each participant was tested with sustained manual glides in each of the possible directions during active wrist flexion and extension from the seated position. For the lateral glide, the therapist stabilises the lateral aspect of the distal radius using the first web-space. And glides the proximal row of carpal bones laterally (towards the thumb) using the first web-space of the other hand, following the joint line. For the medial glide, the therapist stabilises the medial aspect of the distal ulna using the first web-space. And glides the proximal row of carpal bones medially (away from the thumb) using the first web-space of the other hand, following the joint line.
Study NCT05118477 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ambulatory monitoring system
Description: Patients will use AMS.
Study NCT05118477 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ambulatory monitoring system
Description: Patients will use AMS.
Study NCT05118477 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active alerting system
Description: Clinical staff alerted if AMS detects deterioration
Study NCT05631535 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle change program with a very-low-energy diet
Description: The intervention will consist of two phases. In the first phase, the participants receive weekly visits for two months. During these visits, a nutritionist will take the participants' weight and abdominal circumference measurements, and each one will receive a meal plan with a very low-energy diet (800 kcal/d). The second phase will implement in the third and fourth months, and nutritional counseling will continue to be provided every week in the third and biweekly in the fourth month. In this second phase, a gradual reintroduction to low-energy dietary meal plans (1200-1800 kcal/d) will perform. In addition, a specially adapted Diabetes Prevention Program for a very low-energy diet will implement.
Study NCT05631535 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intensive lifestyle change program with a low-energy diet
Description: The structure (frequency of nutritional counseling, number of sessions, time of sessions, etc.) in this group will be the same as that of the intervention group, and a modified Diabetes Prevention Program will also provide. From the beginning of the study will recommend meal plans with a low-energy diet (1200-1800 kcal).
Study NCT05174286 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SBIRT
Description: SBIRT is an evidence-based approach originally designed for people at risk of developing mental disorders. SBIRT is composed of three components: Screening with a validated instrument, Brief Intervention, Referral to Treatment. Motivational Interviewing (MI) is an empirically tested, person-centered, behavior change intervention designed to guide, elicit, and strengthen motivation for change. It decreases ambivalence and increases motivation for treatment.~The investigators will utilize the Culturally-adapted Alive! Program - a cost-effective, lifestyle coaching web-based automated platform that includes step-by-step individualized tailoring, feedback, and weekly guidance through interactive emails focused on increasing physical activity, improving eating habits, and weight control.
Study NCT05174286 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Referral as Usual (RAU)
Description: Referral as Usual will involve distributing CRC health educational materials (e.g. NCI or CDC brochures that include new guidelines) and contact information for screening service providers in our target community.
Study NCT05396976 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga and Muscle Relaxation Exercise Practices
Description: Yoga and Muscle Relaxation Exercise Practices will be done two days a week for 10 weeks.
Study NCT05037266 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine Janssen (Ad26.COV2-S)
Description: one dose (0.5mL) at D1 and one dose (0.5mL) at D57